Modern clinical trials are typically performed as double-blinded, placebo-controlled studies. To meet these needs, Bedrocan now offers placebo versions of all of our strains for use in clinical studies. Each placebo contains the precise terpene profile of the original strain, with all cannabinoids removed.
The method we use to turn active cannabis into placebo uses homogenised cannabis as the starting material. We do this through a process called granulation, where the cannabis is broken up into smaller particles. For that reason, placebo material only comes in the form of granulate.
Full HPLC (high-performance liquid chromatography) and GC (gas chromatography) profiles are available on request, showing detailed information about cannabinoid and terpene content of all varieties.
Click here for more information about our placebo.